About
Jerry McLaughlin is a biopharmaceutical executive who serves as CEO and board member of Life Biosciences, a longevity-focused biotechnology company developing cellular rejuvenation therapies for age-related disease. He previously led Neos Therapeutics and AgeneBio and earlier held senior commercial roles at NuPathe, Endo Pharmaceuticals, and Merck. He also serves as chairman and independent board member at Allarity Therapeutics.
Areas of interest
longevitybiotechaging biologycellular rejuvenationgene therapydrug developmentneuroscienceophthalmologyoncologybiopharma commercialization